Consultation Deadlines

Home  /  Consultation Deadlines
23rd January 2020
FDA revised draft guidance for FDA staff and industry entitled “Drug Products Labeled as Homeopathic.”
7th February 2020
FDA draft guidance for industry entitled “Development of Locally Applied Corticosteroid Products for the Short-Term Treatment of Symptoms Associated with Internal or External Hemorrhoids.”
19th February 2020
FDA draft guidance for industry entitled “Transdermal and Topical Delivery Systems—Product Development and Quality Considerations.”
2nd March 2020
FDA draft guidance for industry entitled “Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS): Establishing Effectiveness of Drugs for Treatment.”
30th April 2020
EMA Scientific guideline: CVMP reflection paper on promoting the authorisation of alternatives to antimicrobials in the EU, draft: consultation open.